MAPK13 and cancer: Even though the single treatment of rapamycin or MAPK13 knockdown reduced the proliferation of mTORC1-hyperactive cancer cells including LAM 621-101, UMB1949, and MCF7, rapamycin was more effective in cell growth suppression when MAPK13 was depleted (Fig. 4, B–D).